Identification of potential hit compounds for Dengue virus NS2B/NS3 protease inhibitors by combining virtual screening and binding free energy calculations

Tropical Biomedicine

Volumn 30, Issue 3, 2013, Pages 388-408

  Wichapong, K ^a   Nueangaudom, A ^a   Pianwanit, S ^a   Sippl, W ^b   Kokpol, S ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NS2B PROTEIN, FLAVIVIRUS; NS3 PROTEASE, DENGUE VIRUS; PROTEINASE INHIBITOR; SERINE PROTEINASE; VIRUS PROTEIN;

ARTICLE; DENGUE VIRUS; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOLECULAR DYNAMICS; PROTEIN BINDING; THERMODYNAMICS;

DENGUE VIRUS; DRUG EVALUATION, PRECLINICAL; MOLECULAR DYNAMICS SIMULATION; PROTEASE INHIBITORS; PROTEIN BINDING; SERINE ENDOPEPTIDASES; THERMODYNAMICS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84884754366     PISSN: 01275720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Aravapalli, S., Lai, H., Teramoto, T., Alliston, K.R., Lushington, G.H., Ferguson, E.L., Padmanabhan, R. & Groutas, W.C. (2012). Inhibitors of Dengue virus and West Nile virus proteases based on the amino-benzamide scaffold. Bioorganic and Medicinal Chemistry 20: 4140-4148.
2. Bayly, C.I., Cieplak, P., Cornell, W. & Kollman, P.A. (1993). A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. The Journal of Physical Chemistry 97: 10269-10280.
3. Billoir, F., de Chesse, R., Tolou, H., de Micco, P., Gould, E.A. & de Lamballerie, X. (2000). Phylogeny of the genus Flavivirus using complete coding sequences of arthropod-borne viruses and viruses with no known vector. Journal of General Virology 81: 781-790.
4. Carlson, H.A., Masukawa, K.M., Rubins, K., Bushman, F.D., Jorgensen, W.L., Lins, R.D., Briggs, J.M. & McCammon, J.A. (2000). Developing a dynamic pharmacophore model for HIV-1 integrase. Journal of Medicinal Chemistry 43: 2100-2114.
5. Case, D.A., Darden, T.A., Cheatham, I.T.E., Simmerling, C.L., Wang, J., Duke, R.E., Luo, R., Merz, K.M., Pearlman, D.A., Crowley, M., Walker, R.C., Zhang, W., Wang, B., Hayik, S., Roitberg, A., Seabra, G., Wong, K.F., Paesani, F., Wu, X., Brozell, S., Tsui, V., Gohlke, H., Yang, L., Tan, C., Mongan, J., Hornak, V., Cui, G., Beroza, P., Mathews, D.H., Schafmeister, C., Ross, W.S. & Kollman, P.A. (2006) AMBER 9. University of California, San Francisco.
6. Chambers, T.J., Hahn, C.S., Galler, R. & Rice, C.M. (1990a). Flavivirus genome organization, expression, and replication. Annual Review of Microbiology 44: 649-688.
7. Chambers, T.J., Weir, R.C., Grakoui, A., McCourt, D.W., Bazan, J.F., Fletterick, R.J. & Rice, C.M. (1990b). Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral poly-protein. Proceedings of the National Academy of Sciences 87: 8898-8902.
8. Darden, T., York, D. & Pedersen, L. (1993). Particle mesh Ewald: An N [center-dot] log(N) method for Ewald sums in large systems. The Journal of Chemical Physics 98: 10089-10092.
9. Deng, J., Lee, K.W., Sanchez, T., Cui, M., Neamati, N. & Briggs, J.M. (2005). Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors. Journal of Medicinal Chemistry 48: 1496-1505.
10. Deng, J., Li, N., Liu, H., Zuo, Z., Liew, O.W., Xu, W., Chen, G., Tong, X., Tang, W., Zhu, J., Zuo, J., Jiang, H., Yang, C.-G., Li, J. & Zhu, W. (2012). Discovery of novel small molecule inhibitors of Dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping. Journal of Medicinal Chemistry 55: 6278-6293.
11. Deng, J., Sanchez, T., Neamati, N. & Briggs, J.M. (2006). Dynamic pharmacophore model optimization: Identification of novel HIV-1 Integrase inhibitors. Journal of Medicinal Chemistry 49: 1684-1692.
12. Falgout, B., Miller, R.H. & Lai, C.J. (1993). Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. Journal of Virology 67: 2034-2042.
13. Falgout, B., Pethel, M., Zhang, Y.M. & Lai, C.J. (1991). Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. Journal of Virology 65: 2467-2475.
14. Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Montgomery, J.J.A., Vreven, T., Kudin, K.N., Burant, J.C., Millam, J.M., Iyengar, S.S., Tomasi, J., Barone, V., Mennucci, B., Cossi, M., Scalmani, G., Rega, N., Petersson, G.A., Nakatsuji, H., Hada, M., Ehara, M., Toyota, K., Fukuda, R., Hasegawa, J., Ishida, M., Nakajima, T., Honda, Y., Kitao, O., Nakai, H., Klene, M., Li, X., Knox, J.E., Hratchian, H.P., Cross, J.B., Bakken, V., Adamo, C., Jaramillo, J., Gomperts, R., Stratmann, R.E., Yazyev, O., Austin, A.J., Cammi, R., Pomelli, C., Ochterski, J.W., Ayala, P.Y., Morokuma, K., Voth, G.A., Salvador, P., Dannenberg, J.J., Zakrzewski, V.G., Dapprich, S., Daniels, A.D., Strain, M.C., Farkas, O., Malick, D.K., Rabuck, A.D., Raghavachari, K., Foresman, J.B., Ortiz, J.V., Cui, Q., Baboul, A.G., Clifford, S., Cioslowski, J., Stefanov, B.B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Martin, R.L., Fox, D.J., Keith, T., Al-Laham, M.A., Peng, C.Y., Nanayakkara, A., Challacombe, M., Gill, P.M.W., Johnson, B., Chen, W., Wong, M.W., Gonzalez, C. & Pople, J.A. (2004). Gaussian 03. Gaussian Inc., Wallingford CT.
15. Ganesh, V.K., Muller, N., Judge, K., Luan, C.-H., Padmanabhan, R. & Murthy, K.H.M. (2005). Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases. Bioorganic and Medicinal Chemistry 13: 257-264.
16. Goodford, P.J. (1985). A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. Journal of Medicinal Chemistry 28: 849-857.
17. GRID22a (2004). Moldiscovery Ltd. Pinner, Middlesex, UK.
18. Gubler, D.J. (1998). Dengue and dengue hemorrhagic fever. Clinical Microbiology Reviews 11: 480-496.
19. st century. Trends in Microbiology 10: 100-103.
20. Gubler, D.J. & Clark, G.G. (1995). Dengue/ dengue hemorrhagic fever: the emergence of a global health problem. Emerging Infectious Diseases 1: 55-57.
21. Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A. & Simmerling, C. (2006). Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Structure, Function, and Bioinforma-tics 65: 712-725.
22. Jones, G., Willett, P. & Glen, R.C. (1995). Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. Journal of Molecular Biology 245: 43-53.
23. Jones, G., Willett, P., Glen, R.C., Leach, A.R. & Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology 267: 727-748.
24. Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W. & Klein, M.L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics 79: 926-935.
25. Keelapang, P., Sriburi, R., Supasa, S., Panyadee, N., Songjaeng, A., Jairungsri, A., Puttikhunt, C., Kasinrerk, W., Malasit, P. & Sittisombut, N. (2004). Alterations of pr-M cleavage and virus export in pr-M junction chimeric Dengue viruses. Journal of Virology 78: 2367-2381.
26. Lescar, J., Luo, D., Xu, T., Sampath, A., Lim, S.P., Canard, B. & Vasudevan, S.G. (2008). Towards the design of antiviral inhibitors against flaviviruses: The case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Research 80: 94-101.
27. Lipinski, C.A., Lombardo, F., Dominy, B.W. & Feeney, P.J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 46: 3-26.
28. Lourenço, J. & Recker, M. (2010). Viral and epidemiological determinants of the invasion dynamics of novel dengue genotypes. PLoS Neglected Tropical Diseases 4: e894.
29. Luo, R., David, L. & Gilson, M.K. (2002). Accelerated Poisson-Boltzmann calculations for static and dynamic systems. Journal of Computational Chemistry 23: 1244-1253.
30. Mahmood, N., Rana, M.Y., Qureshi, Z., Mujtaba, G. & Shaukat, U. (2012). Prevalence and molecular characterization of dengue viruses serotypes in 2010 epidemic. American Journal of the Medicanal Sciences 343: 61-64.
31. MOE 2008.10 (2008) Chemical Computing Group, Inc. Montreal, Canada.
32. Mueller, N.H., Pattabiraman, N., Ansarah-Sobrinho, C., Viswanathan, P., Pierson, T.C. & Padmanabhan, R. (2008). Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen. Antimicrobial Agents and Chemotherapy 52: 3385-3393.
33. Noble, C.G., Seh, C.C., Chao, A.T. & Shi, P.Y. (2012). Ligand-bound structures of the Dengue virus protease reveal the active conformation. Journal of Virology 86: 438-446.
34. Oprea, T. I. (2000). Property distribution of drug-related chemical databases. Journal of Computer-Aided Molecular Design 14: 251-264.
35. Pastor, R.W., Brooks, B.R. & Szabo, A. (1988). An analysis of the accuracy of Langevin and molecular dynamics algorithms. Molecular Physics 65: 1409-1419.
36. Perera, R. & Kuhn, R.J. (2008). Structural proteomics of dengue virus. Current Opinion in Microbiology 11: 369-377.
37. Romano, C.M., de Matos, A.M., Araújo, E.S.A., Villas-Boas, L.S., da Silva, W.C., Oliveira, O.M.N.P.F., Carvalho, K.I., de Souza, A.C.M., Rodrigues, C.L., Levi, J.E., Kallas, E.G. & Pannuti, C.S. (2010). Characterization of Dengue virus type 2: New insights on the 2010 Brazilian epidemic. PLoS ONE 5: e11811.
38. Ryckaert, J.-P., Ciccotti, G. & Berendsen, H.J.C. (1977). Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. Journal of Computational Physics 23: 327-341.
39. Sitkoff, D., Sharp, K.A. & Honig, B. (1994). Accurate calculation of hydration free energies using macroscopic solvent models. The Journal of Physical Chemistry 98: 1978-1988.
40. Steuer, C., Gege, C., Fischl, W., Heinonen, K.H., Bartenschlager, R. & Klein, C.D. (2011). Synthesis and biological evaluation of alpha-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture. Bioorganic and Medicinal Chemistry 19: 4067-4074.
41. Tiew, K.-C., Dou, D., Teramoto, T., Lai, H., Alliston, K.R., Lushington, G.H., Padmanabhan, R. & Groutas, W.C. (2012). Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives. Bioorganic and Medicinal Chemistry 20: 1213-1221.
42. Wang, J., Wolf, R.M., Caldwell, J.W., Kollman, P.A. & Case, D.A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry 25: 1157-1174.
43. Wichapong, K., Pianwanit, S., Sippl, W. & Kokpol, S. (2010). Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction. Journal of Molecular Recognition 23: 283-300.
44. Wolber, G. & Langer, T. (2004). LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling 45: 160-169.